Publications and Presentations

Bibliography 2000 - present

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

---

2009

Andriole GL, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, Crawford ED, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1309-1319.

Baker SG. Improving the biomarker pipeline to develop and evaluate cancer screening tests. J Natl Cancer Inst 2009;101(16):1116-1119.

Baker SG. Putting risk prediction in perspective: relative utility curves. J Natl Cancer Inst 2009;101:1538-1542.

Baker SG, Cook NR, Vickers A, Kramer BS. Using relative utility curves to evaluate risk prediction. Journal of the Royal Statistical Society Series A 2009;172:729-748.

Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD, Kramer BS. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer 2009;9:89. (http://www.biomedcentral.com/1471-2407/9/89)

Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials 2009;4(2):79-88.

Berger VW. Chewing gum and caries. J Am Dent Assoc 2009;140(6)638, 640; author reply 640.

Berger VW. Do methodological flaws invalidate a randomized trial of lifestyle modification programs in obese patients? Ann Intern Med 2009;151(1):70; author reply 70-1.

Berger VW. Do not test for baseline imbalances unless they are known to be present? Qual Life Res 2009;18(4):399.

Berger VW. Polyol-containing chewing gums: flawed evidence. Evid Based Dent 2009;10(2):36; author reply 36.

Berger VW. Right conclusion, wrong method. Eur J Contracept Reprod Health Care 2009;14(4):317-8; author reply 319-20.

Berger VW. The (lack of) quality in assessing the quality of transplantation trials. Transpl Int 2009 May 28;(). doi:10.1111/j.1432-2277.2009.00899.x

Berger VW. Valid, adaptive, data-driven comparisons of binary end points. J Clin Epidemiol 2009;62(10):1112; author reply 1112-3.

Berrigan D, Potischman N, Dodd KW, Hursting SD, Lavigne J, Barrett JC, Ballard-Barbash R. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Grow Horm IGF Res 2009;19(2):146-155.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET, Adenoma Prevention with Celecoxib Study Investigators (Corle D). Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila Pa) 2009;2(4):310-321.

Colón-Ramos U, Thompson FE, Yaroch AL, Moser RP, McNeel TS, Dodd KW, Atienza AA, Sugerman SB, Nebeling L. Differences in Fruit and Vegetable Intake among Hispanic Subgroups in California: results from the 2005 California Health Interview Survey. J Am Diet Assoc 2009;109(11):1878-1885.

Combs GF, Midthune DN, Patterson KY, Canfield WK, Hill AD, Levander OA, Taylor PR, Moler JE, Patterson BH. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 2009;89:1808-1814.

Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu J-L, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE. Cumulative incidence of false-positive results in repeated multimodal cancer screening. Annals of Family Medicine 2009;7(3):212-222.

Doria-Rose VP, Marcus PM. Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer 2009;63(2):295-300.

Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009;115(21):5007-5017.

Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 2009;18(8):2170-2175.

Durkalski VL, Berger VW. Re-formulating non-inferiority trials as superiority trials: the case of binary outcomes. Biom J 2009;51(1):185-192.

Fan Y-G, Hu P, Jiang Y, Chang R-S, Yao S-X, Wang W, He J, Prorok P, Qiao L. Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China. Chest 2009;135(3):778-785.

Gierada DS, Garg K, Nath H, Strollo DC, Fagerstrom RM, Ford MB. CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials. AJR Am J Roentgenol 2009;193(2):419-424.

Gren LH, Broski KG, Childs JC, Cordes JE, Engelhard DA, Gahagan BA, Gamito EJ, Gardner VC, Geisser MS, Higgins DM, Jenkins VL, Lamerato L, Lappe KA, Lowery H, McGuire CJ, Miedzinski MM, Ogden SL, Tenorio SL, Watt GD, Wohlers BL, Marcus PM. Recruitment methods employed in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Clinical Trials 2009;6:52-59.

Grubb RL, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2009;18(3):748-751.

Hewitt CE, Torgerson DJ, Berger VW. Potential for technical errors and subverted allocation can be reduced if certain guidelines are followed: examples from a web-based survey. J Clin Epidemiol 2009;62(3):261-269.

Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 2009;69(7):1288-1295.

Izmirlian G. Prostate-cancer screening. N Engl J Med 2009;361(2):204; author reply 205-206.

Kafadar K, Prorok PC. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected. Stat Med 2009;28(16):2116-2146.

Kipnis V, Midthune D, Buckman DW, Dodd KW, Guenther PM, Krebs-Smith SM, Subar AF, Tooze JA, Carroll RJ, Freedman LS. Modeling data with excess zeros and measurement error: application to evaluating relationships between episodically consumed foods and health outcomes. Biometrics 2009 Feb 26. DOI:10.1111/j.1541-04202009.01223.x [Published online ahead of print].

Lacey JV, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P, PLCO Cancer Screening Trial Project Team. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial cohort. BMC Cancer 2009 Mar 17. [Published online http://www.biomedcentral.com/1471-2407/9/84]

Laiyemo AO, Jack M, Dawkins FW, Smoot DT. Upper gastrointestinal bleeding from metastatic testicular cancer. J Natl Med Assoc 2009;101(8):808-809.

Laiyemo AO, Murphy G, Sansbury LB, Wang Z, Albert PS, Marcus PM, Schoen RE, Cross AJ, Schatzkin A, Lanza E. Hyperplastic polyps and the risk of adenoma recurrence in the Polyp Prevention Trial. Clin Gastroenterol Hepatol 2009;7(2):192-197.

Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ, Schatzkin A, Schoen RE. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 2009;7(5):562-567; quiz 497.

Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D. Are patterns of health behavior associated with cancer screening? Am J Health Promot 2009;23(3):168-175.

Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. Int J Cancer 2009;124(9):2148-2151.

Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A. Hormone therapy in relation to survival from large bowel cancer. Cancer Causes Control 2009;20(4):409-416.

Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, Kessel B, Johnson CC, Weissfeld L, Isaacs C, Andriole GL, Ogden S, Ragard LR, Buys SS. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009;113(4):775-782.

Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA, Doria-Rose VP, Prorok P. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 2009;7(1):86-92.

Ransohoff DF. Promises and limitations of biomarkers. Recent Results Cancer Res 2009;181:55-59.

Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 2009;150(1):50-52.

Rosenfeld S. Characteristics of transcriptional activity in nonlinear dynamics of genetic regulatory networks. Gene Regulation and Systems Biology 2009;3:159-179.

Rosenfeld S. Origins of stochasticity and burstiness in high-dimensional biochemical networks. EURASIP J Bioinform Syst Biol 2009; Article ID 362309.
(EURASIP J Bioinform Syst Biol. 2009; 2009: 362309. Published online 2008 October 16. doi: 10.1155/2009/362309)

Rosenfeld S. Patterns of stochastic behavior in dynamically unstable high-dimensional biochemical networks. Gene Regulations and Systems Biology 2009;(3):1-10.

Sansbury LB, Wanke K, Albert PS, Kahle L, Schatzkin A, Lanza E, Polyp Prevention Trial Study Group (Corle D). The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence. Am J Epidemiol 2009;170(5):576-584.

Schatzkin A, Subar AF, Moore S, Park Y, Potischman N, Thompson FE, Leitzmann M, Hollenbeck A, Morrissey KG, Kipnis V. Observational epidemiologic studies of nutrition and cancer: the next generation (with better observation). Cancer Epidemiol Biomarkers Prev 2009;18(4):1026-32.

Tamers SL, Agurs-Collins T, Dodd KW, Nebeling L. US and France adult fruit and vegetable consumption patterns: an international comparison. Eur J Clin Nutr 2009;63:11-17.

Tammemagi M, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, Ragard LR, Berg CD, Prorok PC. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 2009;4(6):710-721.

Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, Caporaso NE, Schatzkin A, Cross AJ. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 2009;89(6):1884-1894.

Thompson FE, McNeel TS, Dowling EC, Midthune D, Morrissette M, Zeruto CA. Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc 2009;109(8):1376-1383.

Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, Ransohoff DF. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009;150(12):849-857, W152.

Weiss NS, Doria-Rose VP. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 2009;150(11):817-818; author reply 819-820.

Wirfält E, Midthune D, Reedy J, Mitrou P, Flood A, Subar AF, Leitzmann M, Mouw T, Hollenbeck AR, Schatzkin A, Kipnis V. Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study. Eur J Clin Nutr 2009;63(6):707-717.

Xu J-L, Prorok PC. On testing independence of repeated screening tests (letter). J Med Screen 2009;16(1):50. (doi:10.1258/jms.2008.008097).

2008

Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 2008;168(3):268-277.

Baker SG. Two simple approaches for validating a binary surrogate endpoint using data from multiple trials. Stat Methods Med Res 2008;17(5):505-514.

Baker SG, Kramer BS. Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests. J Med Screen 2008;15:18-22.

Baker SG, Kramer BS. Using microarrays to study the microenvironment in tumor biology: the crucial role of statistics. Semin Cancer Biol 2008;18(5):305-310.

Baker SG, Kramer BS, Prorok PC. Early reporting for cancer screening trials. J Med Screen 2008;15(3):122-129.

Berger VW. Controversies in clinical trials. Stat Methods Med Res 2008;17(3):229-230.

Berger VW. Regarding paper "A note on P-values for two-sided tests". Biom J 2008;50(6):1093-1095; author reply 1096-1097.

Berger VW, Matthews JR, Grosch EN. On improving research methodology in clinical trials. Stat Methods Med Res 2008;17(3):231-242.

Berger VW, Zhang S, Zhou YY. Comment on Fygenson. Statistica Sinica 2008;18:55-58.

Flood A, Rastogi T, Wirfält E, Mitrou PN, Reedy J, Subar AF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary patterns as identified by factor analysis and colorectal cancer among middle-aged Americans. Am J Clin Nutr 2008;88(1):176-184.

Freedman LS, Kipnis V, Schatzkin A, Potischman N. Methods of epidemiology: evaluating the fat-breast cancer hypothesis--comparing dietary instruments and other developments. Cancer J 2008;14(2):69-74.

Freedman LS, Midthune D, Carroll RJ, Kipnis V. A comparison of regression calibration, moment reconstruction and imputation for adjusting for covariate measurement error in regression. Stat Med 2008;27(25):5195-5216.

Gierada DS, Pilgram TK, Ford M, Fagerstrom RM, Church TR, Nath H, Garg K, Strollo DC. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology 2008;246(1):265-272.

Greene GW, Resnicow K, Thompson FE, Peterson KE, Hurley TG, Hebert JR, Toobert DJ, Williams GC, Elliot DL, Goldman Sher T, Domas A, Midthune D, Stacewicz-Sapuntzakis M, Yaroch AL, Nebeling L. Correspondence of the NCI Fruit and Vegetable Screener to repeat 24-H recalls and serum carotenoids in behavioral intervention trials. J Nutr 2008;138(1):200S-204S.

Grubb RL, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int 2008;102(11):1524-1530.

Hebert JR, Hurley TG, Peterson KE, Resnicow K, Thompson FE, Yaroch AL, Ehlers M, Midthune D, Williams GC, Greene GW, Nebeling L. Social desirability trait influences on self-reported dietary measures among diverse participants in a multicenter multiple risk factor trial. J Nutr 2008;138(1):226S-234S.

Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359(12):1218-1224.

Izmirlian G. Reply to "Open Source Mathematical Software". Notices of the American Mathematical Society 2008;55(3):342.

Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR, Xu JL, Buys SS. The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. Gynecol Oncol 2008;110(3):383-389.

Kipnis V, Freedman LS. Impact of exposure measurement error in nutritional epidemiology. J Natl Cancer Inst 2008;100(23):1658-1659.

Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008;68(4 Suppl):S3-47.

Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z, Cross AJ, Marcus PM, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery ML, Burt R, Iber F, Shike M, Kikendal JW, Lanza E, Schatzkin A. Postpolypectomy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 2008;148:419-426.

Laiyemo AO, Smoot DT. Metastatic gastric stump cancer occurring six years after a partial gastrectomy for gastric ulcer. J Natl Med Assoc 2008;100(6):737-739.

Lamerato LE, Marcus PM, Jacobsen G, Johnson CJ. Recruitment in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: The Henry Ford Health System Experience. Cancer Epidemiol Biomarkers Prev 2008;17:827-833.

Midthune D, Kipnis V, Freedman LS, Carroll RJ. Binary regression in truncated samples, with application to comparing dietary instruments in a large prospective study. Biometrics 2008;64:289-98.

Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Dopamine D(2) receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. Int J Cancer 2008;Oct 20:______.

Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control 2008;19(7):751-758.

Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2008;100:291-298.

Ransohoff DF. The process to discover and develop biomarkers for cancer: a work in progress. J Natl Cancer Inst 2008;100(20):1419-1420.

Ransohoff DF, Martin C, Wiggins WS, Hitt BA, Keku TO, Galanko JA, Sandler RS. Assessment of serum proteomics to detect large colon adenomas. Cancer Epidemiol Biomarkers Prev 2008;17(8):2188-2193.

Reedy J, Mitrou PN, Krebs-Smith SM, Wirfält E, Flood A, Kipnis V, Leitzmann M, Mouw T, Hollenbeck A, Schatzkin A, Subar AF. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2008;168(1):38-48.

Rosenfeld S. Approximate bivariate gamma generator with prespecified correlation and different marginal shapes. ACM Trans Model Comput Simul 2008;18(4:Article 16):16:1-16:20.

Rosenfeld S. Why do high-dimensional networks seem to be stable?-A reflection on stochasticity of dynamically unstable nonlinear systems. In Gauges R, Kummer U, Pahle J, Willy P , editors. Fifth Workshop on Computation of Biochemical Pathways and Genetic Networks. Heidelberg: University of Heidelberg, 2008:101-112.

Rosenfeld S, Kapetanovic I. Systems biology and cancer prevention: all options on the table. Gene Regulations and Systems Biology 2008;2:307-319.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev 2008;17(4):799-804.

Stewart J, Ware J, Boysen C, Gulati S, Zhou Z, Rosenfeld S, Kopelovich L, Kennedy AR. Effects of selenomethionine on the gene expression profile of cloned human prostate cancer cells representing a phenotypic continuum of cancer progression. Nutr Cancer 2008;60(6):826-836.

Thiébaut AC, Kipnis V, Schatzkin A, Freedman LS. The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer--a story with twists and turns. Cancer Invest 2008;26(1):68-73.

Thompson FE, Kipnis V, Midthune D, Freedman LS, Carroll RJ, Subar AF, Brown CC, Butcher MS, Mouw T, Leitzmann M, Schatzkin A. Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr 2008;11(2):183-195.

Thompson FE, Midthune D, Williams GC, Yaroch AL, Hurley TG, Resnicow K, Hebert JR, Toobert DJ, Greene GW, Peterson K, Nebeling L. Evaluation of a short dietary assessment instrument for percentage energy from fat in an intervention study. J Nutr 2008;138(1):193S-199S.

Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Prevalence of physical activity among youth and adults in the United States as measured by accelerometer in the National Health and Nutrition Examination Survey (NHANES) 2003-2004. Med Sci Sports Exercise 2008;40:181-188.

Williams GC, Hurley TG, Thompson FE, Midthune D, Yaroch AL, Resnicow K, Toobert DJ, Greene GW, Peterson K, Nebeling L, Patrick H, Hardin JW, Hebert JR. Performance of a short percentage energy from fat tool in measuring change in dietary intervention studies. J Nutr 2008;138(1):212S-217S.

Yanetz R, Kipnis V, Carroll RJ, Dodd KW, Subar AF, Schatzkin A, Freedman LS. Using biomarker data to adjust estimates of the distribution of usual intakes for misreporting: application to energy intake in the US population. J Am Diet Assoc 2008;108(3):455-464; discussion 464.

Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Med Care 2008;46(9 Suppl 1):S138-146.

Back to Top

2007

Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, Schatzkin A. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol 2007;166(1):36-45.

Ahn J, Schatzkin A, Lacey JV Jr, Albanes D, Ballard-Barbash R, Adams KF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann MF. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007;167(19):2091-2102.

Baker SG. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2007;99(6)487-489.

Baker SG. Letter to the editor on causal inference for vaccines. Journal of the American Statistical Association 2007;102:394.

Baker SG, Frangakis C, Lindeman KS. Estimating efficacy in a proposed randomized trial with initial and later noncompliance. Journal of the Royal Statistical Society, Series C 2007;56:211-221.

Baker SG, Kaprio J. Genes, cancer, and twins--the statistics behind the headlines. Chance 2007;20,:59-62.

Baker SG, Kramer BS. Randomized trials for the real world: making as few and as reasonable assumptions as possible. Stat Methods Med Res 2007 Oct 9 [Epub as doi:10.1177/0962280207080640 [Abstract] [OnlineFirst PDF]]

Baker SG, Kramer BS. Paradoxes in carcinogenesis: New opportunities for research directions. BMC Cancer 2007;7:151.

Baker SG, Kramer BS. Peirce, Youden, and Receiver Operating Characteristic Curves. The American Statistician 2007; November:343-346.

Berger VW. Controversies in clinical trials part I. Stat Methods Med Research 2007 Oct 9 [Epub ahead of print]

Berger VW. Drawbacks to non-integer scoring for ordered categorical data. Biometrics 2007;63(1):298-299.

Berger VW, Gee E. On confusing prima facie validity with true validity. Br J Dermtol 2007;157(2):425-426.

Berger VW, Matthews JR, Grosch EN. On improving research methodology in clinical trials. Stat Methods Med Res 2007 Oct 9 [Epub ahead of print]

Berrigan D, Potishman N, Dodd K, Micar M, McQuillan, Lavinge J, Barrett JC, Ballard-Barbash R. Serum levels of insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein-3 (IGFBP-3): quality control for studies of stored serum. Cancer Epidemiol Biomarkers Prev 2007;16:1017-1022.

Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A, Leitzmann MF. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007;18(5):493-503.

Davidov O, Hu P. Early detection programs in medical care. In Ruggeri F, Kenett R, Faltin F, editors. Encyclopedia of Statistics in Quality and Reliability. Chichester (U.K.): John Wiley & Sons, 2007:583-589.

Fletcher RH, Ransohoff DF, Imperiale TF. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2007;109(9):1925-1926; author reply 1926.

Freedman LS, Schatzkin A, Thiébaut AC, Potischman N, Subar AF, Thompson FE, Kipnis V. Abandon neither the food frequency questionnaire nor the dietary fat-breast cancer hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16(6):1321-1322.

Howerton MW, Bell BS, Dodd KW, Berrigan D, Stolzenberg-Solomon R, Nebeling L. School-based nutrition programs produced a moderate increase in fruit and vegetable consumption: meta and pooling analyses from 7 studies. J Nutr Educ Behav 2007;39(4):186-196.

Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med 2007;22(8):1195-1205.

Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, Hartge P. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166(6):697-708.

Lissner L, Troiano RP, Midthune D, Heitmann BL, Kipnis V, Subar AF, Potischman N. OPEN about obesity: recovery biomarkers, dietary reporting errors and BMI. Int J Obes (Lond) 20073;(Epub ahead of print).

Marcus PM. MRI evaluation of breast cancer. N Engl J Med 2007;357(2):192; author reply 193.

Midthune D, Kipnis V, Freedman LS, Carroll RJ. Binary regression in truncated samples, with application to comparing dietary instruments in a large prospective study. Biometrics 2007 Jul 25; [Epub ahead of print]

Mitrou PN, Kipnis V, Thiébaut AC, Reedy J, Subar AF, Wirfält E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 2007;167(22):2461-2468.

Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter, JD. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007;67(15):7534-7539.

Pandya K, Hu P, Osborne CK, Falkson G, Tormey DC. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer. An Eastern Cooperative Oncology Group Intergroup Study (E3185). American Journal of Clinical Oncology 2007;30(2):113-125.

Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2007;166(11):1270-1279.

Park Y, Subar AF, Kipnis V, Thompson FE, Mouw T, Hollenbeck A, Leitzmann MF, Schatzkin A. Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol 2007;166(2):170-180.

Patterson BH, Wastney ME, Combs GF. Calculation of the amounts of organic and inorganic selenium in the human diet from kinetic studies. In Hanigan MD, Novotny JA, Marstellar CL (eds). Mathematical Modeling in Nutrition and the Health Sciences. Blacksburg, VA:Virginia Institute of Technology 2007;213-222.

Ransohoff DF. What is the role of iFOBT in screening for colorectal cancer? Gut 2007;56(10):1343-1344.

Ransohoff DF. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. J Clin Epidemiol 2007;60(12):1205-1219.

Rosenfeld S. Stochastic cooperativity in non-linear dynamics of genetic regulatory networks. Mathematical Biosciences 2007;210:121-142.

Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, Leitzmann MF, Thompson FE. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr 2007;85(5):1353-1360.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev 2007;16(10):2118-2127.

Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, Hollenbeck A, Schatzkin A, Sinha R. Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 2007;16(12):2664-2675.

Tammemagi CM, Freedman MT, Church TR, Oken MM, Hocking WG, Kvale PA, Hu P, Riley TL, Ragard LR, Prorok PC, Berg CD. Factors associated with human small aggressive non small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2007;16(10):2082-2089.

Thiébaut AC, Freedman LS, Carroll RJ, Kipnis V. Is it necessary to correct for measurement error in nutritional epidemiology? Ann Intern Med 2007;146(1):65-67.

Thiébaut AC, Kipnis V. Dietary fat underreporting and risk estimation. Public Health Nutr 2007;10(2):212-214.

Thiébaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007;99(6):451-462.

Thompson FE, Midthune D, Subar AF, Kipnis V, Kahle LL, Schatzkin A. Development and evaluation of a short instrument to estimate usual dietary intake of percentage energy from fat. J Am Diet Assoc 2007;107(5):760-767.

Tooze JA, Schoeller DA, Subar AF, Kipnis V, Schatzkin A, Troiano RP. Total daily energy expenditure among middle-aged men and women: the OPEN Study. Am J Clin Nutr 2007;86(2):382-387.

Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, Kramer BS, Ransohoff DF. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 2007;167(21):2289-2295.

Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007;109(4):675-684

Vogt TM, Ziegler RG, Patterson BH, Graubard BI. Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2007;166(3):280-288.

Xu J-L. On estimating a survival function under the generalized proportional hazards model. Journal of Statistical Planning & Inference 2007;137:1161-1172.

Back to Top

2006

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med 2006;355(8):763-778.

Baker SG. A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint. Biostatistics 2006 Jan;7(1)58-70.

Baker SG. Surrogate endpoints: wishful thinking or reality? (Editorial). Journal of the National Cancer Institute 2006;98(8):502-503.

Baker SG. Screening and breast cancer. Letter to the editor. New England Journal of Medicine 2006;354:767-768.

Baker SG, Kaprio J. Response to letter from Professor Lubinski regarding "Common susceptibility genes for cancer: search for the end of the rainbow". British Medical Journal 2006, Rapid Response

Baker SG, Fitzmaurice GM, Freedman LS, Kramer BS. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates. Biostatistics 2006 Jan;7(1)29-40.

Baker SG, Kaprio J. Common susceptibility genes for cancer: search for the end of the rainbow. British Medical Journal 2006;332:1150-1152.

Baker SG, Kramer BS. Identifying genes that contribute most to good classification in microarrays. BMC Bioinformatics 2006;7:407.

Baker SG, Kramer BS. Why biotechnologists should care about biostatistics. Asia-Pacific Biotech News 2006(30 November);10(22):1275-1278.

Baker SG, Kramer BS, Lindeman KS. The paired availability design: if you can't randomize, perhaps this applies. Chance 2006;19:57-60.

Baker SG, Kramer BS, McIntosh M, Patterson BH, Shyr Y, Skates S. Evaluating markers for the early detection of cancer: overview of study designs and methods of analysis. Clinical Trials 2006;3:43-56.

Berger VW. A review of methods for ensuring the comparability of comparison groups in randomized clinical trials. Rev Recent Clin Trials 2006;1(1):81-86.

Berger VW. Missing data should be more heartily penalized. Journal of Clinical Epidemiology 2006;59:759-760.

Berger VW. Do not use blocked randomization. Headache 2006;46(2)343-345.

Berger VW. Can pain be quantified numerically? J Rheumatol 2006;33(11):2364-2365.

Berger VW. Critical appraisal of individual trials? American Journal of Gastroenterology 2006;101(5):1156-1157.

Berger VW. Is the Jadad score the proper evaluation of trials? J Rheumatol 2006;33(8):1710-1712.

Berger VW. Misguided precedent is not a reason to use permuted blocks. Headache 2006;46(7):1210-1212.

Berger VW. Response to Klassen et al: Missing data should be more heartily penalized. Journal of Clinical Epidemiology 2006;59(7):759-760.

Berger VW. Varying the block size does not conceal the allocation. Journal of Critical Care 2006;21(2):229-230.

Berger VW, Matthews Jr. What does biostatistics mean to us? Mens Sana Monographs III 2006;6(Ivm 1-4):89-103.

Berger VW, Stefanesco C. The analysis of stratified 2x2 contingency tables. Biometrical Journal 2006;48(6):992-1007.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET; APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. New England Journal of Medicine 2006;355(9):873-884.

Carroll RJ, Midthune D, Freedman LS, Kipnis V. Seemingly unrelated measurement error models, with application to nutritional epidemiology. Biometrics 2006;62(1):75-84.

Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK. Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. J Urol 2006;175(4):1286-1290.

Dodd KW, Guenther PM, Freedman LS, Subar AF, Kipnis V, Midthune D, Tooze JA, Krebs-Smith SM. Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc 2006;106(10):1640-1650.

Dorgan JF, McMahon RP, Friedman LA, Van Horn L, Snetselaar LG, Kwiterovich PO, Lauer RM, Lasser NL, Stevens VJ, Robson A, Cooper SF, Chandler DW, Franklin FA, Barton BA, Patterson BH, Taylor PR, Schatzkin A. Diet and sex hormones in boys: findings from the dietary intervention study in children. J Clin Endocrinol Metab 2006;91(10):3992-3996.

Dores GM, Chang S, Berger VW, Perkins SN, Hursting SD, Weed DL. Evaluating research training outcomes: experience from the Cancer Prevention Fellowship Program at the National Cancer Institute. Academic Medicine 2006;81(6):535-541.

Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R, Subar AF. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol 2006;35(4):1011-1021.

Izmirlian G. Response to "Receiver operating characteristics of the prostate-specific antigen test in an unselected population." J Med Screen 2006;13(4):214-215.

Lacey JV, Greene MH, Buys SS, Reding D, Riley TL, Berg CD, Fagerstrom RM, Hartge P. Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstetrics and Gynecology 2006;108(5):1176-1184.

Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. Journal of the National Cancer Institute 2006;98(11):748-756.

Marcus PM. Lung cancer screening. In: Jeffries LP (ed). Lung Cancer Screening. Hauppauge, NY:Nova Science Publishers, 2006;51-80.

Millen AF, Midthune D, Thompson FE, Kipnis V, Subar AF. The National Cancer Institute diet history questionnaire: validation of pyramid food servings. Am J Epidemiol 2006;163(3)279-288.

Rosenfeld S. A nonlinear continuous stochastic model for genetic regulatory networks. caveats for microarray data analysis. Proceedings of the 10th International Conference on the Simulation and Synthesis of Living Systems, Bloomington, IN, June 3-7, 2006, pp. 28-34.

Rosenfeld S. Stochastic oscillations in genetic regulatory networks. EURASIP Journal of Bioinformatics and Systems Biology 2006;Article ID 59256:1-12.

Rosenfeld S. Stochastic oscillations in genetic regulatory networks. application to microarray experiments. In: A.Rizzi, M.Vichi (ed). Proceedings in Computational Statistics Proceedings COMPSTAT 2006. Rome, Italy:Physica-Verlag, 2006;1609-1618

Steele VE, Arnold JT, Le H, Izmirlian G, Blackman MR. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells. Anticancer Research 2006;26:3205-3216.

Subar AF, Dodd KW, Guenther PM, Kipnis V, Midthune D, McDowell M, Tooze JA, Freedman LS, Krebs-Smith SM. The food propensity questionnaire: concept, development, and validation for use as a covariate in a model to estimate usual food intake. J Am Diet Assoc 2006;106(10):1556-1563.

Thiébaut AC, Schatzkin A, Ballard-Barbash R, Kipnis V. Dietary fat and breast cancer: contributions from a survival trial. J Natl Cancer Inst 2006;98(24):1753-1755.

Tooze JA, Midthune D, Dodd KW, Freedman LS, Krebs-Smith SM, Subar AF, Guenther PM, Carroll RJ, Kipnis V. A new statistical method for estimating the usual intake of episodically consumed foods with application to their distribution. J Am Diet Assoc 2006;106(10):1575-1587.

Valente AXCN, Cusick ME. Yeast protein interactome topology provides framework for coordinated-functionality. Nucleic Acids Research 2006;34:2812-2819.

Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: a systematic approach. Trials 2006;7:30.

Weiss NS, Doria-Rose VP. Colorectal cancer risk following a negative colonoscopy. JAMA 2006;296(20):2436-2438.

Xu J-L, Izmirlian G. Estimation of location parameters for spherically symmetric distributions. Journal of Multivariate Analysis 2006;97:514-525.

Back to Top

2005

Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK, for the PLCO Project Team. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. Journal of the National Cancer Institute 2005;97:433-438.

Baker SG. A simple loglinear model for haplotype effects in a case-control study involving two unphased genotypes. Statistical Applications in Genetics and Molecular Biology 2005;4(1):14.

Baker SG, Izmirlian G, Kipnis V. Resolving paradoxes involving surrogate endpoints. J R Statist Soc A 2005;168(4):753-762.

Baker SG, Kramer BS. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis. Statistical Methods in Medical Research 2005;14:349-367.

Baker SG, Kramer BS. Statistics for weighing benefits and harms in a proposed genetic substudy of a randomized cancer prevention trial. J R Statist Soc C (Applied Statistics) 2005;54(5):941-954.

Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics 2005;61(1):55-63.

Berger VW. Allocation concealment and blinding: when ignorance is bliss. Med J Aust 2005;183(3):165-166.

Berger VW. A novel criterion for selecting covariates. Drug Information Journal 2005;39:233-241.

Berger VW. A review of methods for ensuring the comparability of comparison groups in randomized trials. Reviews on Recent Clinical Trials 2005;1(1):81-86.

Berger VW. Nonparametric adjustment techniques for binary covariates. Biometrical Journal 2005;47(2):199-205.

Berger VW. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials (with discussion). Biometrical Journal 2005;47(2):119-127.

Berger VW. The reverse propensity score to detect selection bias and correct for baseline imbalances. Stat Med 2005;24(18):2777-2787.

Berger VW. Training statisticians to be alert to the dangers of mis-applying statistical methods when they do not apply. Journal of Modern Applied Statistical Methods 2005;4(2):587-590.

Berger VW. What is to be done about selection bias. Biometrical Journal 2005;47(2):136-139.

Berger VW, Durkalski VL. Analysis of trichotomous pharmaceutical endpoints. J Biopharm Stat 2005;15(4):739-745.

Berger VW, Hsieh G. Rethinking statistics: basing efficacy alpha levels on safety data in randomized trials. Israeli Journal of Emergency Medicine 2005;5(3):55-60.

Berger VW, Matthews JR. Conducting today’s trials by tomorrow’s standards. Pharmaceutical Statistics 2005;4:155-159.

Berger VW, Semanick L. Refining the assessment of the sensitivity and specificity of diagnostic tests, with applications to prostate cancer screening and non-small cell lung cancer staging. Rev Panam Salud Publica 2005;18(1):64-70.

Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, Hartge P, Fagerstrom RM, Ragard LR, Chia D, Izmirlian G, Fouad M, Johnson CC, Gohagan JK, for the PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193(5):1630-1639.

Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ. Modeling the dissemination of mammography in the United States. Cancer Causes Control 2005;16(6):701-712.

Gohagan JK, Marcus PM, Fagerstrom RM, Black WC, Kramer BS, Pinsky PF, Prorok PC. Screening for lung cancer. In Gibson PG, Abramson M, Wood-Baker R, Volmink J, Hensley M, Costabel U (eds). Evidence-Based Respiratory Medicine. Malden, MA:Blackwell Publishing, 2005;81-87.

Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C; the Lung Screening Study Research Group. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47(1):9-15.

Ivanova A, Barrier RC Jr, Berger VW. Adjusting for observable selection bias in block randomized trials. Stat Med 2005;24(10):1537-1546.

Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 2004;1020:154-174.

Kafadar K, Prorok PC. Computational methods in medical decision making: to screen or not to screen? Statistics in Medicine 2005;24(4):569-581.

Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A. Comparison of cancer registry ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Management 2005;32:70-75.

Midthune D, Fay MP, Clegg LX, Feuer EJ. Modeling reporting delays and reporting corrections in cancer registry data. Journal of the American Statistical Association 2005;100:61-70.

Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace P, Levin DL, Prorok PC, Gohagan JK for the PLCO Project Team. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2005; 97(24):1832-1839.

Pinsky PF, Marcus PM, Kramer BS, Freedman M, Nath H, Kvale P, Reding D. Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen. Cancer 2005;103:157-163.

Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC. Gohagan JK for the PLCO Project Team. Prostate biopsy following a positive screen in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Journal of Urology 2005;173:746-751.

Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005;5(2):142-149.

Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst 2005;97(4):315-319.

Thompson FE, Midthune D, Subar AF, McNeel T, Berrigan D, Kipnis V. Dietary intake estimates in the National Health Interview Survey, 2000: methodology, results, and interpretation. J Am Diet Assoc 2005;105(3):352-363; quiz 487.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK, PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97(13):989-997.

Xu J-L. On improved estimates of location in the presence of an unknown scale. In Fan J, Li G (eds). Contemporary Multivariate Analysis and Experimental Design -- In Honor Celebration of Professor Kai-Tai Fang's 65th Birthday. Singapore:The World Scientific Publisher, 2005;435-443.

Back to Top

2004

Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee. The Prostate, Lung, Colon, and Ovarian (PLCO) Cancer Screening Trial: status and promise. Urology Oncology 2004;22(4):358-361.

Baker SG, Freedman LS. Correction: a simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Medical Research Methodology 2004;4(1):1.

Baker SG, Kramer BS, Corle D. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"? BMC Medical Research Methodology 2004(Oct 4);4:24.

Baker SG, Kramer BS, Prorok PC. Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design. BMC Medical Research Methodology 2004(May 18);4(1):12.

Baker SG, Kramer BS, Prorok PC. Development tracks for cancer prevention markers. Dis Markers 2004;20(2):97-102.

Berger VW. Does the Prentice criterion validate surrogate endpoints? Statistics in Medicine 2004;23(10):1571-1578.

Berger VW. On the generation and ownership of alpha in medical studies. Controlled Clinical Trials 2004;25(6):613-619.

Berger VW. Selection bias and baseline imbalances in radomized trials. Drug Information Journal 2004;38:1-2.

Berger VW. Validate adjustment for binary covariates of randomized binary comparisons. Biometrical Journal 2004;46(5):589-594.

Berger VW, Ioannidis JP. The Decameron of poor research. British Medical Journal 2004;239:1436-1440.

Berger VW, Weinstein S. Ensuring the comparability of comparison groups: is randomization enough? Controlled Clinical Trials 2004;25(5):515-524.

Berger VW, Zhou YY, Ivanova A, Tremmel L. Adjusting for ordinal covariates by including a partial ordering. Biometrical Journal 2004;46(1):48-55.

Freedman LS, Fainberg V, Kipnis V, Midthune D, Carroll RJ. A new method for dealing with measurement error in explanatory variables of regression models. Biometrics 2004;60(1):172-181.

Freedman LS, Midthune D, Carroll RJ, Krebs-Smith S, Subar AF, Troiano RP, Dodd K, Schatzkin A, Ferrari P, Kipnis V. Adjustments to improve the estimation of usual dietary intake distributions in the population. Journal of Nutrition 2004;134(7):1836-1843.

Fuchs C, Berger VW. Quantifying the proportion of cases attributable to an exposure. Journal of Modern Applied Statistical Methods 2004;3(1):54-64.

Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph. the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-112

Hu P, Zelen M. Planning of randomized early detection trials. Statistical Methods in Medical Research 2004;13:419-506.

Imperiale TE, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross Imperiale TE, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714.

Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 2004;1020:154-174.

Kapetanovic IM, Rosenfeld S, Izmirlian G. Overview of commonly used bioinformatics methods and their applications. Ann NY Acad Sci 2004;1020:10-21.

Krebs-Smith SM, Subar AF, Guenther P, Tooze JA, Midthune D, Kipnis V, Dodd K. Food propensity questionnaires (FPQs) in the National Health and Nutrition Examination Survey (NHANES): a step in the evolution of usual dietary intake estimation. FASEB J 2004;18:A480.

Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Clinton SK, Fraser G, Freedman L, Hunter D, Kipnis V, Kolonel LN, Kristal BS, Kristal A, Lampe JW, McTiernan A, Milner J, Patterson RE, Potter JD, Riboli E, Schatzkin A, Yates A, Yetley E. Nutrition and physical activity and chronic disease prevention: research strategies and recommendations. Journal of the National Cancer Institute 2004;96(17):1276-1287.

Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4(4):309-314.

Rosenfeld S. A new method for testing normality based on properties of hermite orthogonal polynomials. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 739-755 (ISSN#1550-3747).

Rosenfeld S. Sampling from the bivariate gamma distribution with specified correlation coefficient and different marginal distributions. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 756-772 (ISSN#1550-3747).

Rosenfeld S. New develop ments in cancer-related computational statistics. Ann NY Acad Sci 2004;1020:22-31.

Rosenfeld S, Wang T, Kim Y, Milner J. Numerical deconvolution of cDNA microarray signal: simulation study. Ann NY Acad Sci 2004;1020:110-123.

Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition cancer questions? Journal of the National Cancer Institute 2004;96(21):1564-1565.

Subar AF, Dodd K, Thompson FE, Kipnis V, Midthune D, Krebs-Smith SM. What, exactly, is the food propensity questionnaire? FASEB J 2004;18:A481.

Thompson FE, Midthune D, Subar AF, Kahle LL, Schatzkin A, Kipnis V. Performance of a short tool to assess dietary intakes of fruits and vegetables, percentage energy from fat and fibre. Public Health Nutrition 2004;7(8):1097-1105.

Tooze JA, Dodd KN, Midthune D, Krebs-Smith SM, Subar AF, Kipnis V. Estimating the distribution of usual intake of episodically consumed foods using two 24-hour recalls and a food propensity questionnaire, FASEB J 2004;18:A481.

Tooze JA, Subar AF, Thompson FE, Troiano R, Schatzkin A, Kipnis V. Psychosocial predictors of energy underreporting in a large doubly labeled water study. American Journal of Clinical Nutrition 2004;79(5):795-804.

Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU. Serum proteomic profiles suggest celecoxib-modulated targets and response predictors. Cancer Res 2004;64(8):2904-2909.

Xu J-L, Fagerstrom RM, Prorok PC, Kramer BS. Estimating the cumulative risk of a false-positive test in a repeated screening program. Biometrics 2004;60:651-660.

Back to Top

2003

Baker SG. The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst 2003;95(7):511-515.

Baker SG, Chia-Wen K, Graubard B. A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey. Biostatistics 2003;1:41-56.

Baker SG, Erwin D, Kramer BS, Prorok PC. Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening. BMC Medical Research Methodology 2003(6 Mar);3:4.

Baker SG, Freedman LS. A simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Medical Research Methodology 2003;3:8.

Baker SG, Kramer BS. Correction: the transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology 2003;3:23.

Baker SG, Kramer BS. A perfect correlate does not a surrogate make. BMC Medical Research Methodology 2003;3:16.

Baker SG, Kramer BS. Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes. BMC Medical Research Methodology 2003(16 Jun);3:10.

Baker SG, Kramer BS. Estimating the cumulative risk of false positive cancer screenings. BMC Medical Research Methodology 2003(03 Jul ),3:11.

Berger VW. Additional reflections on significance testing. Journal of Modern Applied Statistical Methods 2003;2(2):5124-515.

Berger VW. Further analysis of the Gallin Itraconazole Trial. New England Journal of Medicine 2003;349(12):1190-1191.

Berger VW, Bears J. When can a clinical trial be called 'randomized'? Vaccine 2003;21:468-472.

Berger VW, Christophi CA. Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. Journal of Modern Applied Statistical Methods 2003;2(1):80-86.

Berger VW, Ivanova A, Knoll MD. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Statistics in Medicine 2003;22(19):3017-3028.

Berger VW, Rezvani A, Makarewicz V. Direct effect on validity of response run-in selection in clinical trials. Controlled Clinical Trials 2003;24(2):156-166.

Church TR (for the National Lung Screening Trial Executive Committee). Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003;10:713-715.

Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich Jr. PO, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR. Diet and sex hormones in girls: Findings from a randomized controlled clinical trial. J Natl Cancer Inst 2003;95(2):132-141.

Forman MR, Ballard-Barbash R, Kipnis V. Nutritional strategies for breast cancer prevention: what have we learned and where do we go from here? Cancer 2003;98(9):1782-1785.

Gohagan JK, Marcus PM, Fagerstrom RM, Black WC, Kramer BS, Pinsky PF, Prorok PC. Screening for lung cancer. In Williams C (ed). Evidence-Based Oncology. London:BMJ Books, 2003;164-171.

Gulyaeva N, Zaslavsky A, Lechner P, Chlenov M, McConnell O, Chait A, Kipnis V, Zaslavsky B. Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. a simple model for predicting blood—brain distribution. Eur J Medicinal Chemistry 2003;38(4):391-396.

Kafadar K, Prorok PC. Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials. Statistics in Medicine 2003;22:83-111.

Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, Bingham S, Schoeller DA, Schatzkin A, Carroll RJ. Structure of dietary measurement error: Results of the OPEN Biomarker Study. American Journal of Epidemiology 2003;158(1):14-21.

Kipnis V, Subar AF, Schatzkin A, Midthune D, Troiano RP, Schoeller DA, Bingham S, Freedman LS. Kipnis et al. respond to “OPEN questions”. Am J Epidemiol 2003;158(1):25-26.

Marcus PM. Conflicting evidence in lung cancer screening: Randomized controlled trials versus case-control studies. Lung Cancer 2003;41:37-39.

Michaud DS, Troiano RP, Subar AF, Runswick S, Bingham S, Kipnis V, Schatzkin A. Comparison of estimated renal net acid excretion from dietary intake and body size with urine pH. Journal of the American Dietetic Association 2003;103(8):1001-1007.

Ransohoff DF. Developing molecular biomarkers for cancer. Science 2003;299:1679-1680.

Schatzkin A, Kipnis V, Carroll RJ, Midthune D, Subar AF, Bingham S, Schoeller DA, Troiano RP, Freedman LS. A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study. International Journal of Epidemiology 2003;32(6):1054-1062.

Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK, for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003;290(1):41-48.

Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, Sunshine J, Schatzkin A. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. American Journal of Epidemiology 2003;258(1):1-13.

Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 2003;14(5):403-411.

Trabulsi J, Troiano RP, Subar AF, Sharbaugh C, Kipnis V, Schatzkin A, Schoeller DA. Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study. European Journal of Clinical Nutrition 2003;57(11):1370-1377.

Xu J-L, Prorok PC. Modelling and analysing exchangeable binary data with random cluster sizes. Statistics in Medicine 2003;22:2401-2416

Back to Top

2002

Baker SG, Kramer BS. The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology 2002(13 Nov);2(1):13.

Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Medical Research Methodology 2002 (19 Sept);2:11.

Baker SG, Kramer BS, Srivastava S. Markers for early detection of cancer: Statistical issues for nested case-control studies. BMC Medical Research Methodology 2002;2:4.

Baker SG, Tockman MS. Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention. Statistics in Medicine 2002;21:2383-2390.

Berger VW. Improving the information content of categorical clinical trial endpoints. Controlled Clinical Trials 2002;23:502-514.

Berger VW, Ivanova A. Bias of linear rank tests for stochastic order in ordered categorical data. Journal of Statistical Planning and Inference 2002;107(1):237-247.

Berger VW, Ivanova A. Adaptive tests for ordinal data. Journal of Modern Applied Statistical Methods 2002;1(2):269-280.

Berger VW, Lunneborg C, Ernst MD, Levine JG. Parametric analyses in randomized clinical trials. Journal of Modern Applied Statistical Methods 2002:1(1):74-82.

Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-1545.

de Koning HJ, Auvinen A, Sanchez AB, da Silva FC, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH for the ERSPC and the PLCO Trials: Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer Trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial. Int J Cancer 2002;97:237-244.

Dorgan JF, Fears T, McMahon RP, Friedman LA, Patterson BH, Greenhut S. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151-158.

Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA, Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156(2):95-109.

Kipnis V, Izmirlian G. The impact of categorization of continuous exposure measured with error. Am J Epidemiol 2002;155:S28.

Kipnis V, Izmirlian G, Midthune D, Subar A, Schatzkin A. Misclassification of dietary exposure and its implications: results from the Observing Protein and Energy Nitrition (OPEN) biomarker study. Am J Epidemiol 2002;155:S28.

Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ. Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutrition 2002;5:915-923.

Marcus PM, Fagerstrom RM, Prorok PC, Gohagan JK, Kramer BS. Screening for lung cancer with helical CT scanning. Clinical Pulmonary Medicine 2002;9:323-329.

Marcus PM. Lung cancer screening, once again (letter). Chest 2002;122:3.

Marcus PM, Travis WD. Lung. In Franco EL, Rohan TE (eds). Cancer Precursors. New York, NY: Springer-Verlag, 2002:201-219.

Patterson BH, Dayton CM, Graubard BI. Latent class analysis of complex sample survey data: Application to dietary data. Journal of the American Statistical Society 2002;97:721-734.

Patterson BH, Dayton CM, Graubard BI. Rejoinder. Journal of the American Statistical Society 2002;738-741.

Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA. Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States. Cancer Causes Control 2002;13:937-946.

Ransohoff DF. Challenges and opportunities in evaluating diagnostic tests. J Clin Epid 2002;55:1178-1182.

Schatzkin A, Kipnis V, Subar A, Troiano R, Midthune D, Bingham S, Schoeller D. Food frequency questionnaire may seriously attenuate association between diet and disease: results from the OPEN (Observing Protein and Energy Nutrition) biomarker study. Am J Epidemiol 2002;155:S28.

Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E, Corle D, Begg CB, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. Journal of Clinical Oncology 2002;20(17):3592-3598.

Stables GJ, Subar AF, Patterson BH, Dodd K, Heimendinger J, Van Duyn MA, Nebeling L. Changes in vegetable and fruit consumption and awareness among US adults. results of the 1991 and 1997 5 A Day for Better Health Program surveys. J Am Diet Assoc 2002;102(6):809-817.

Thompson FE, Subar AF, Smith AF, Midthune D, Radimer KL, Kahle LL, Kipnis V. Fruit and vegetable assessment: Performance of 2 new short instruments and a food frequency questionnaire. J Am Diet Assoc 2002;102:1764-1772.

Thomson FE, Patterson BH, Weinstein SJ, McAdams M, Spate VL, Hamman RF, Levine RS, Mallin K, Stolley PD, Brinton LA, Morris JS, Ziegler RG. Serum selenium and the risk of cervical cancer among women in the United States. Cancer Causes and Controls 2002;13:517-526.

Tooze J, Subar A, Thompson F, Troiano R, Schatzkin A, Kipnis V. Psychosocial predictors of energy underreporting in a large doubly labeled water study. Am J Epidemiol 2002;155:S56.

Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer 2002;94:2569-2576.

Back to Top

2001

Baker SG. Evaluating periodic cancer screening without a randomized control group: a simplified design and analysis. In: Duffy SW, Hill C, Esteve J (eds). Quantitative Methods for the Evaluation of Cancer Screening. London: Edward Arnold Limited, 2001;34-41.

Baker SG, Lindeman KL. Rethinking historical controls. Biostatistics 2001,2:383-396.

Baker SG, Lindeman, KS. Randomized and nonrandomized studies. statistical considerations (editorial). Anesthesiology 2000;92:928-930.

Baker SG. Discussion of doubling sampling with survival analysis. Biometrics 2001;57:348-350.

Baker SG, Pinsky P. A proposed design and analysis for comparing digital and analog mammography: special ROC methods for cancer screening. Journal of the American Statistical Association 2001;96:421-428.

Baker SG, Kramer BS. Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. Journal of Women's Health & Gender-Based Medicine 2001;10:867- 872.

Baker SG, Lindeman KL, Kramer BS. The paired availability design for historical controls. BMC Medical Research Methodology 2001;1:9.

Berger VW, Ivanova A. Permutation tests for phase III clinical trials. In: Millard SP, Krause A (eds). Applied Statistics in the Pharmaceutical Industry with Case Studies Using S-PLUS. New York: Springer-Verlag, New York, 2001;349-374.

Berger VW. The p-value interval as an inferential tool. Journal of the Royal Statistical Society D 2001;50(1):79-85.

Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001;37:261-267.

Corle DK, Sharbaugh C, Mateski DJ, Coyne T, Paskett ED, Cahill J, Daston C, Lanza E, Schatzkin A, the PPT Study Group. Self-rated quality of life measures: effect of change to a low-fat, high-fiber, fruit and vegetable enriched diet. Ann Behav Med 2001;23(3):198-207.

Frangakis C, Baker SG. Compliance adjusted double-sampling designs for comparative research: estimation and optimal planning. Biometrics 2001;57:899-908.

Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology 2001;58:561-566.

Honkanen V, Szalai JP, Siegel JN, Siegel A, Berger VW, Feldman BM. A three-phase clinical trial design for rare disorders. Statistics in Medicine 2001;20:3009-3021.

Ivanova A, Berger V. Drawbacks to integer scoring for ordered categorical data. Biometrics 2001;57:567-570.

Jiang WX, Kipnis V, Midthune D, Carroll RJ. Parameterization and inference for nonparametric regression problems. Journal of the Royal Statistical Society, Series B 2001;63(3):583-591.

Kipnis V, Midthune D, Freedman LS, Bingham S, Subar A, Schatzkin A, Carroll RJ. Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol 2001;153:394-403.

Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, Caan B, Lance P, Marshall J, Iber F, Shike M, Weissfeld J, Slattery M, Paskett E, Mateski D, the PPT Study Group. Implementation of a 4-year high fiber, high fruit/vegetable, low fat dietary intervention: results of dietary change in the Polyp Prevention Trial. Am J Clin Nutr 2001;74(3):387-401.

Marcus PM. Lung cancer screening: an update. J Clin Oncol 2001;19S:83S-86S.

McShane LM, Midthune DN, Dorgan JF, Freedman LS, Carroll RJ. Covariate measurement error adjustment for matched case-control studies. Biometrics 2001;57:62-73.

Melzer D, Izmirlian G, Leveille SG, Guralnik JM. Educational differences in the prevalence of mobility disability in old age: the dynamics of incidence, mortality, and recovery. Journal of Gerontology: SOCIAL SCIENCES 2001;56B(5):S294-S301.

Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001;23(1):181-186.

Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V. Design and serendipity in establishing a large cohort with wide dietary intake distributions - the National Institutes of Health-American Association of Retired Persions Diet and Health Study. Am J Epidemiol 2001;154(12):1119-1125.

Spiegelman D, Carroll R, Kipnis V. Efficient regression calibration for logistic regression for main study/internal validation study designs with an imperfect reference instrument. Stat Med 2001;20:139-160.

Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001;154(12):1089-1099.

Subar AF, Thompson FE, Kipnis V. Subar et al. respond to “A further look at dietary questionnaire validation” and “Another perspective on food frequency questionnaires”. Am J Epidemiol 2001;154(12):1105-1106.

Back to Top

2000

Baker SG, Lindeman KS. Randomized and nonrandomized studies. Statistical considerations (editorial). Anesthesiology 2000;92:928-30.

Baker SG. Analyzing a randomized cancer prevention trial with a missing binary outcome, an auxiliary variable, and all-or-none compliance. J Am Stat Assoc 2000;95:43-50.

Baker SG. Identifying combinations of cancer biomarkers for further study as triggers of early intervention. Biometrics 2000;56:1082-1087.

Berger VW. Critique of Ludbrook and Dudley. American Statistician 2000;54(1):85-86.

Berger VW. Pros and cons of permutation tests. Stat Med 2000;19:1319-1328.

Buyske S, Fagerstrom R, Ying Z. A class of weighted log-rank tests for survival data when the event is rare. J Am Stat Assoc 2000;95:249-258.

Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am J Epidemiol 2000;151(10):991-998.

Gohagan JK, Levin DL, Prorok PC, Sullivan D (eds). The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):249S-406S.

Gohagan JK, Prorok PC, Hayes R, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000;21(6 Suppl):251S-272S.

Hartge P, Hayes R, Reding D, Sherman ME, Prorok P, Schiffman M, Buys S. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial. Am J Obstet Gynecol 2000;183(5):1232-1237.

Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):329S-348S.

Havlik RJ, Izmirlian G, Petrovitch H, Ross GW, Masaki K, Curb JD, Saunders AM, Foley DJ, Brock DB, Launer LJ, White L. APOE-epsilon4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54;1526-1529.

Izmirlian G, Brock DB, Ferrucci L, Phillips C. Active life expectancy from annual follow-up data with missing responses. Biometrics 2000;56(1):244-248

Izmirlian G, Brock DB, White L. Estimating incidence of dementia sub-types: assessing the impact of missed cases. Stat Med 2000;19:1577-1591.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with application to cancer rates. Stat Med 2000;19:335-351.

Kipnis V, Carroll RJ, Freedman LS, Li L. Re: "Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies" The authors reply (letter). Am J Epidemiol 2000;152:495-496.

Kulldorff M, McShane LM, Schatzkin A, Freedman LS, Wargovich MJ, Woods C, Purewal M, Burt RW, Lawson M, Mateski DJ, Lanza E, Corle DK, O'Brien B, Moler J. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays. J Clin Epidemiol 2000;53(8):875-883.

Leveille SG, Pennix BW, Melzer D, Izmirlian G, Guralnik JM. Sex differences in the prevalence of mobility misability in old age: the dynamics of incidence, recovery and mortality. J Gerontol B Psychol Sci Soc Sci 2000;55(1):S41-S50.

Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316.

Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9(5):461-467.

Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The association of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk. Cancer Causes Control 2000;11:271-278.

Marcus PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 studies. Pharmacogenetics 2000;10:115-122.

Marcus PM. Television as a venue for cancer education: the General Hospital experience. J Cancer Educ 2000;15:4.

Masaki K, Losonsczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik RJ, White L. Association of vitamin E and C supplement use with cognitive function and dementia in elderly Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54(6):1265-1272

Masaki KH, White LR, Foley DJ, Petrovitch H, Izmirlian G, Havlik R, Ross GW, Losonczy KG. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men - Reply. Neurology 2000;55(6):901-902.

O'Brien B, Nichaman L, Browne JEH, Levin DL, Prorok PC, Gohagan JK. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):310S-328S.

Permutt T, Berger VW. Rank tests in ordered 2xk contingency tables. Communications in Statistics, Theory and Methods 2000;29(5):989-1003.

Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 2000;21:57-62

Prorok PC, Andriole GL, Bresalier R, Buys S, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes R, Johnson CC, Mandel JS, O'Brien B, Oken M, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):273S-309S.

Rosenfeld S, Grody N. Metamorphic signature of snow revealed in SSM/I measurements. IEEE Transactions on Geoscience and Remote Sensing 2000;38(1):53-63.

Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, fruit- and vegetable-enriched diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342(16):1149-1155.

Stein, M, Rich J, Maksad J, Chen MH, Hu P, Sobota M, Clark J. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000;26(2):195-205.

Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A. Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 2000;152:279-286.

Thompson FE, Kipnis V, Subar AF, Krebs-Smith SM, Kahle LL, Midthune D, Potischman N, Schatzkin A. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr 2000;71:1503-1510.

Weissfeld JL, Fagerstrom RM, O'Brien B. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):390S-399S.

Back to Top